Intervention

Total-Body Irradiation

ClinicalTrials.gov intervention label

Clinical trials2
Recruiting0
Common conditions25
Lead sponsors shown2

Common conditions

Acute Lymphoblastic Leukemia2Acute Myeloid Leukemia2Chronic Myelogenous Leukemia, BCR-ABL1 Positive2Myelodysplastic Syndrome2Myelodysplastic Syndrome With Excess Blasts2Non-Hodgkin Lymphoma2Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Acute Biphenotypic Leukemia1Acute Erythroid Leukemia1Acute Leukemia1Acute Lymphoblastic Leukemia in Remission1Acute Megakaryoblastic Leukemia1Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome1Chemotherapy-Related Leukemia1Chronic Lymphocytic Leukemia1Chronic Myelomonocytic Leukemia1Hematopoietic and Lymphoid Cell Neoplasm1HIV Infection1Hodgkin Lymphoma1Langerhans Cell Histiocytosis1Minimal Residual Disease1Recurrent Hodgkin Lymphoma1Refractory Acute Lymphoblastic Leukemia1Refractory Anemia1Refractory Myelodysplastic Syndrome1

Trial status mix

COMPLETED1
TERMINATED1

Phase mix

PHASE22

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.